News

Under the terms of the funding agreement, which is in support of Compugen’s Pipeline Program, Baize Investments has obtained a financial interest in five designated Compugen-discovered molecules and

Phase II clinical trials of Multikine demonstrated the product was safe and well-tolerated and eliminated tumors in 12% of the subjects less than a month into treatment. CEL-SCI

In a filing to the Bombay Stock Exchange, Surya Pharmaceuticals said the transaction was financed through a mix of internal accruals and debt from EXIM Bank. With this

RPS offers clients a broad spectrum of outsourcing solutions ranging from globally embedded functional and cross-functional solutions to enhanced global full-service solutions. RPS CEO and chairman Daniel Perlman

Cumberland has informed the US Food and Drug Administration (FDA) of its plan to voluntarily recall these lots of Acetadote as a precautionary measure. According to the company,

MannKind claims that Afrezza is a novel, ultra rapid acting mealtime insulin therapy being developed by MannKind Corporation for the treatment of adult patients with type 1 and

As per the approval, Sinovac is required to conduct each phase of the human clinical trials in accordance with SFDA requirements, to conduct studies to assess safety and

The safety and efficacy of Rhucin for the treatment of HAE attacks were evaluated in two randomized placebo-controlled studies and are supported by four open label treatment studies.

Nuvigil is indicated to improve wakefulness in patients with excessive sleepiness associated with treated obstructive sleep apnea (OSA), shift work disorder (SWD), or narcolepsy. In its letter to